Ameloblastoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 6: | Line 6: | ||
Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years. | Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Regular follow-up examination with the physician is very important in managing ameloblastoma. | *Regular follow-up examination with the physician is very important in managing [[ameloblastoma]]. | ||
*For ameloblastoma follow up should occur at regular intervals for at least 10 years | *For [[ameloblastoma]] patients follow up should occur at regular intervals for at least 10 years. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 17:24, 17 October 2018
Ameloblastoma
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years.
Secondary Prevention
- Regular follow-up examination with the physician is very important in managing ameloblastoma.
- For ameloblastoma patients follow up should occur at regular intervals for at least 10 years.